ArticleFrontiers in oncology2021

Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study.

György Rokszin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.